These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1533 related items for PubMed ID: 25517311

  • 21. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
    Buchegger F, Pèlegrin A, Hardman N, Heusser C, Lukas J, Dolci W, Mach JP.
    Int J Cancer; 1992 Feb 01; 50(3):416-22. PubMed ID: 1735611
    [Abstract] [Full Text] [Related]

  • 22. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ, Garvin D, Paguio A, Moravec R, Engel L, Fan F, Surowy T.
    J Immunol Methods; 2014 Dec 01; 414():69-81. PubMed ID: 25086226
    [Abstract] [Full Text] [Related]

  • 23. Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis.
    López AF, Begley G, Andrews P, Butterworth AE, Vadas MA.
    J Immunol; 1985 Jun 01; 134(6):3969-77. PubMed ID: 3989303
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF, Pinedo HM, Schlüper HM, Nijman HW, Boven E.
    Br J Cancer; 1992 May 01; 65(5):677-83. PubMed ID: 1586596
    [Abstract] [Full Text] [Related]

  • 25. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 26. A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies.
    Fan X, Brezski RJ, Deng H, Dhupkar PM, Shi Y, Gonzalez A, Zhang S, Rycyzyn M, Strohl WR, Jordan RE, Zhang N, An Z.
    Mol Cancer Ther; 2015 Mar 01; 14(3):681-91. PubMed ID: 25552368
    [Abstract] [Full Text] [Related]

  • 27. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU, Fumia S.
    Autoimmun Rev; 2008 Jun 01; 7(6):508-13. PubMed ID: 18558371
    [Abstract] [Full Text] [Related]

  • 28. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
    Fumia S, Goede JS, Fischler M, Luginbühl A, Frick S, Fodor P, Lutz HU.
    Mol Immunol; 2008 May 01; 45(10):2951-61. PubMed ID: 18339427
    [Abstract] [Full Text] [Related]

  • 29. The antigen binding domain of non-idiotypic human anti-F(ab')2 autoantibodies: study of their interaction with IgG hinge region epitopes.
    Welschof M, Reineke U, Kleist C, Kipriyanov S, Little M, Volkmer-Engert R, Schneider-Mergener J, Opelz G, Terness P.
    Hum Immunol; 1999 Apr 01; 60(4):282-90. PubMed ID: 10363719
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia.
    Cheney CM, Stephens DM, Mo X, Rafiq S, Butchar J, Flynn JM, Jones JA, Maddocks K, O'Reilly A, Ramachandran A, Tridandapani S, Muthusamy N, Byrd JC.
    MAbs; 2014 Apr 01; 6(3):749-55. PubMed ID: 24594909
    [Abstract] [Full Text] [Related]

  • 32. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 33. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL, Koefoed K, Geisler C, Gadeberg OV, Frank DA, Petersen J, Jurlander J, Pedersen MW.
    Br J Haematol; 2013 Oct 01; 163(2):182-93. PubMed ID: 23927424
    [Abstract] [Full Text] [Related]

  • 34. Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.
    Stein R, Qu Z, Chen S, Solis D, Hansen HJ, Goldenberg DM.
    Blood; 2006 Oct 15; 108(8):2736-44. PubMed ID: 16778139
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.
    MAbs; 2015 Oct 15; 7(4):743-51. PubMed ID: 25970007
    [Abstract] [Full Text] [Related]

  • 36. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO, Qu Z, Hansen HJ, Shih LB, Wang J, Losman MJ, Goldenberg DM, Sharkey RM.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [Abstract] [Full Text] [Related]

  • 37. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
    Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P, Krammer PH.
    J Immunol; 1992 Nov 15; 149(10):3166-73. PubMed ID: 1431095
    [Abstract] [Full Text] [Related]

  • 39. Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.
    Huang T, Mathieu M, Lee S, Wang X, Kee YS, Bevers JJ, Ciferri C, Estavez A, Wong M, Chiang NY, Nakamura G, Brezski RJ.
    J Biol Chem; 2018 Jan 19; 293(3):906-919. PubMed ID: 29191832
    [Abstract] [Full Text] [Related]

  • 40. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z, Masui H, Altas I, Mendelsohn J.
    Cancer Res; 1993 Sep 15; 53(18):4322-8. PubMed ID: 8364927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.